Literature DB >> 6321544

Immunity to human cytomegalovirus measured and compared by complement fixation, indirect fluorescent-antibody, indirect hemagglutination, and enzyme-linked immunosorbent assays.

J A Brandt, J D Kettering, J E Lewis.   

Abstract

The complement fixation test is currently the test employed most frequently to determine the presence of antibody to human cytomegalovirus. Several other techniques have been adapted for this purpose. A comparison of cytomegalovirus antibody titers was made between the complement fixation test, a commercially available enzyme-linked immunosorbent assay, an indirect immunofluorescent technique, and a modified indirect hemagglutination test. Forty-three serum samples were tested for antibodies by each of the above procedures. The enzyme-linked immunosorbent, immunofluorescent, and indirect hemagglutination assays were in close agreement on all samples tested; the titers obtained with these methods were all equal to or greater than the complement fixation titer for 38 of the 41 samples (92.6%). Two samples were anticomplementary in the complement fixation test but gave readable results in the other tests. The complement fixation test was the least sensitive of the procedures examined. The commercial enzyme-linked immunosorbent assay system was the most practical method and offered the highest degree of sensitivity in detecting antibodies to cytomegalovirus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321544      PMCID: PMC271005          DOI: 10.1128/jcm.19.2.147-152.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  Cytomegalovirus and blood transfusion in neonates.

Authors:  J W Benson; S J Bodden; J O Tobin
Journal:  Arch Dis Child       Date:  1979-07       Impact factor: 3.791

2.  A comparison of complement fixation, indirect immunofluorescence for viral late antigens, and anti-complement immunofluorescence tests for the detection of cytomegalovirus specific serum antibodies.

Authors:  P D Griffiths; K J Buie; R B Heath
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

3.  Comparison of occurrence of antibodies to human cytomegalovirus as demonstrated by immunofluorescence and indirect hemagglutination techniques.

Authors:  S Michelson; N Cabau; A Boue; F Horodniceanu
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

4.  Anti-complement immunofluorescence test for antibodies to human cytomegalovirus.

Authors:  J D Kettering; N J Schmidt; D Gallo; E H Lennette
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

5.  Asymptomatic cytomegalovirus infection following blood transfusion in tumor surgery.

Authors:  D P Stevens; L F Barker; A S Ketcham; H M Meyer
Journal:  JAMA       Date:  1970-02-23       Impact factor: 56.272

6.  Cytomegaloviremia following congenital infection.

Authors:  D J Lang; B Noren
Journal:  J Pediatr       Date:  1968-12       Impact factor: 4.406

7.  Cytomegalovirus infection and the postperfusion syndrome. Recognition of primary infections in four patients.

Authors:  D J Lang; J B Hanshaw
Journal:  N Engl J Med       Date:  1969-05-22       Impact factor: 91.245

Review 8.  Assessment of human cytomegalovirus antibody detection techniques.

Authors:  F Horodniceanu; S Michelson
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

9.  Improved indirect hemagglutination test for cytomegalovirus using human O erythrocytes in lysine.

Authors:  A S Yeager
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

10.  Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay.

Authors:  E F Torrey; R H Yolken; C J Winfrey
Journal:  Science       Date:  1982-05-21       Impact factor: 47.728

View more
  8 in total

1.  Evaluation of four methods for cytomegalovirus antibody detection for use by a bone marrow transplantation service.

Authors:  D S Leland; K A Barth; E B Cunningham; J Jansen; G J Tricot; M L French
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

2.  Latex agglutination and enzyme-linked immunosorbent assays for cytomegalovirus serologic screening of transplant donors and recipients.

Authors:  S W Chou; K M Scott
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

3.  Latex agglutination test for detecting CMV antibodies in patients awaiting bone marrow transplantation.

Authors:  P R Hunter; E Evans; S J May
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

4.  Comparison of a latex agglutination test with five other methods for determining the presence of antibody against cytomegalovirus.

Authors:  D G Beckwith; D C Halstead; K Alpaugh; A Schweder; D A Blount-Fronefield; K Toth
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

5.  Screening tests for antibodies to cytomegalovirus: an evaluation of five commercial products.

Authors:  P C Grint; C J Ronalds; H O Kangro; A Campbell-Benzie; F Ward; A E Hardiman; R B Heath
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

6.  Comparison of six methods for the detection of antibody to cytomegalovirus.

Authors:  T M McHugh; C H Casavant; J C Wilber; D P Stites
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

7.  Cytomegalovirus antigenic heterogeneity can cause false-negative results in indirect hemagglutination and complement fixation antibody assays.

Authors:  R G Faix
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

8.  Viral reactivation as a cause of unexplained fever in patients with progressive metastatic breast cancer.

Authors:  S Rasoul-Rockenschaub; C C Zielinski; C Müller; E Tichatschek; T Popow-Kraupp; C Kunz
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.